ASPIRIN LINK TO DECREASED COLORECTAL CANCER RISK SUPPORTED
This article was originally published in The Tan Sheet
Executive Summary
ASPIRIN LINK TO DECREASED COLORECTAL CANCER RISK SUPPORTED by the results of a prospective cohort study of 47,900 male health professionals published in the Aug. 15 issue of Annals of Internal Medicine. The analysis of the Health Professionals Follow-Up Study, conducted by Edward Giovannucci, MD, Harvard Medical School, et al., "supports laboratory, clinical, and other epidemiological evidence that regular use of aspirin is associated with a decreased risk of colorectal cancer."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning